In this study, we administrated the [177Lu]Lu-DOTAGA.(SA.FAPi)2 to kill CAFs and surrounding tumor cells, resulting in a reduced secretion of CXCL12 (Supplemental Fig. 10). The gene discussed is CXCL12; the disease is neoplasm.